ImmunoGen Inc (NASDAQ:IMGN)

2.46
Delayed Data
As of Apr 18
 -0.07 / -2.77%
Today’s Change
2.27
Today|||52-Week Range
12.31
-48.75%
Year-to-Date
Here's Why ImmunoGen Tumbled 43% in March
Apr 08 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.53
Today’s open2.53
Day’s range2.41 - 2.57
Volume3,143,382
Average volume (3 months)3,278,906
Market cap$874.0M
Data as of 4:00pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)-23.11%
Earnings growth (this year)+9.33%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-53.71%
P/E ratioNM
Price/Sales12.57
Price/Book79.66

Competitors

 Today’s
change
Today’s
% change
KZRKezar Life Sciences ...-0.77-3.85%
MRUSMerus NV+0.55+3.63%
ADVMAdverum Biotechnolog...+0.33+5.84%
UBXUnity Biotechnology ...+0.16+2.04%
Data as of 4:00pm ET, 04/18/2019

Financials

Next reporting dateMay 3, 2019
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$53.4M
Annual profit (last year)-$168.8M
Net profit margin-315.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer, CFO &
Director
Mark J. Enyedy
Chief Scientific Officer &
EVP-Research
Richard J. Gregory
Corporate headquarters
Waltham, Massachusetts

Forecasts